Table
of Contents
|
|
|
Chapter 1 |
Orientation to Pharmacology |
1 |
Chapter 2 |
Application of Pharmacology in Nursing Practice |
2 |
Chapter 3 |
Drug Regulation, Development, Names, and Information |
4 |
Chapter 4 |
Pharmacokinetics |
5 |
Chapter 5 |
Pharmacodynamics |
8 |
Chapter 6 |
Drug
Interactions |
9 |
Chapter 7 |
Adverse Drug Reactions and Medication Errors |
11 |
Chapter 8 |
Individual Variation in Drug Responses |
13 |
Chapter 9 |
Drug Therapy during Pregnancy and Breast-Feeding |
14 |
Chapter 10 |
Drug Therapy in Pediatric Patients |
16 |
Chapter 11 |
Drug Therapy in Geriatric Patients |
17 |
Chapter 12 |
Basic Principles of Neuropharmacology |
19 |
Chapter 13 |
Physiology of the Peripheral Nervous System |
20 |
Chapter 14 |
Muscarinic Agonists and Antagonists |
22 |
Chapter 15 |
Cholinesterase Inhibitors and Their Use in
Myasthenia Gravis |
25 |
Chapter 16 |
Drugs that Block Nicotinic Cholinergic Transmission: Neuromuscular Blocking Agents and Ganglionic Blocking Agents |
27 |
Chapter 17 |
Adrenergic Agonists |
29 |
Chapter 18 |
Adrenergic Antagonists |
31 |
Chapter 19 |
Indirect-Acting Antiadrenergic Agents |
34 |
Chapter 20 |
Introduction to Central Nervous System Pharmacology |
36 |
Chapter 21 |
Drugs for Parkinson’s Disease |
37 |
Chapter 22 |
Alzheimer’s Disease |
39 |
Chapter 23 |
Drugs for Multiple Sclerosis |
42 |
Chapter 24 |
Drugs for Epilepsy |
45 |
Chapter 25 |
Drugs for Muscle Spasm and Spasticity |
49 |
Chapter 26 |
Local Anesthetics |
51 |
Chapter 27 |
General Anesthetics |
53 |
Chapter 28 |
Opioid (Narcotic) Analgesics, Opioid Antagonists, and Nonopioid
Centrally Acting Analgesics |
55 |
Chapter 29 |
Pain Management in Patients with Cancer |
59 |
Chapter 30 |
Drugs for Headache |
61 |
Chapter 31 |
Antipsychotic Agents and Their Use in Schizophrenia |
64 |
Chapter 32 |
Antidepressants |
66 |
Chapter 33 |
Drugs for Bipolar Disorder |
70 |
Chapter 34 |
Sedative-Hypnotic Drugs |
73 |
Chapter 35 |
Management of Anxiety Disorders |
75 |
Chapter 36 |
Central Nervous System Stimulants and Attention-Deficit/Hyperactivity
Disorder |
78 |
Chapter 37 |
Drug Abuse I: Basic
Considerations |
81 |
Chapter 38 |
Drug Abuse II: Alcohol |
83 |
Chapter 39 |
Drug Abuse III: Nicotine and Smoking |
86 |
Chapter 40 |
Drug Abuse IV: Major Drugs of Abuse Other Than Alcohol and Nicotine |
87 |
Chapter 41 |
Diuretics |
90 |
Chapter 42 |
Agents Affecting the Volume and Ion Content of
Body Fluids |
94 |
Chapter 43 |
Review of Hemodynamics |
96 |
Chapter 44 |
Drugs Acting on the Renin-Angiotensin-Aldosterone
System |
99 |
Chapter 45 |
Calcium Channel Blockers |
102 |
Chapter 46 |
Vasodilators |
105 |
Chapter 47 |
Drugs for Hypertension |
107 |
Chapter 48 |
Drugs for Heart Failure |
110 |
Chapter 49 |
Antidysrhythmic Drugs |
113 |
Chapter 50 |
Prophylaxis of Coronary Heart Disease: Drugs That
Help Normalize Cholesterol and Triglyceride Levels |
117 |
Chapter 51 |
Drugs for Angina Pectoris |
119 |
Chapter 52 |
Anticoagulant, Antiplatelet,
and Thrombolytic
Drugs |
123 |
Chapter 53 |
Management of ST-Elevation Myocardial Infarction |
127 |
Chapter 54 |
Drugs for Hemophilia |
129 |
Chapter 55 |
Drugs for Deficiency Anemias |
132 |
Chapter 56 |
Hematopoietic Agents |
135 |
Chapter 57 |
Drugs for Diabetes Mellitus |
138 |
Chapter 58 |
Drugs for Thyroid Disorders |
143 |
Chapter 59 |
Drugs Related to Hypothalamic and Pituitary Function |
146 |
Chapter 60 |
Drugs for Disorders of the Adrenal Cortex |
149 |
Chapter 61 |
Estrogens and Progestins:
Basic Pharmacology
and Noncontraceptive Applications |
151 |
Chapter 62 |
Birth Control |
153 |
Chapter 63 |
Drug Therapy of Infertility |
157 |
Chapter 64 |
Drugs that Affect Uterine Function |
159 |
Chapter 65 |
Androgens |
161 |
Chapter 66 |
Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia |
163 |
Chapter 67 |
Review of the Immune System |
166 |
Chapter 68 |
Childhood Immunization |
168 |
Chapter 69 |
Immunosuppressants |
172 |
Chapter 70 |
Antihistamines |
175 |
Chapter 71 |
Cyclooxygenase Inhibitors: Nonsteroidal Anti-inflammatory Drugs
and Acetaminophen |
177 |
Chapter 72 |
Glucocorticoids in Nonendocrine Disorders |
181 |
Chapter 73 |
Drug Therapy of Rheumatoid Arthritis |
183 |
Chapter 74 |
Drug Therapy of Gout |
186 |
Chapter 75 |
Drugs Affecting Calcium Levels and Bone
Mineralization |
187 |
Chapter 76 |
Drugs for Asthma |
192 |
Chapter 77 |
Drugs for Allergic Rhinitis, Cough, and Colds |
196 |
Chapter 78 |
Drugs for Peptic Ulcer Disease |
199 |
Chapter 79 |
Laxatives |
203 |
Chapter 80 |
Other Gastrointestinal Drugs |
206 |
Chapter 81 |
Vitamins |
209 |
Chapter 82 |
Drugs for Weight Loss |
212 |
Chapter 83 |
Basic Principles of Antimicrobial Therapy |
214 |
Chapter 84 |
Drugs That Weaken the Bacterial Cell Wall I: Penicillins |
217 |
Chapter 85 |
Drugs That Weaken the Bacterial Cell Wall II: Cephalosporins, Carbapenems, Vancomycin, Telavancin, Aztreonam, Teicoplanin, and Fosfomycin |
220 |
Chapter 86 |
Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and
Others |
223 |
Chapter 87 |
Aminoglycosides: Bactericidal Inhibitors of Protein
Synthesis |
227 |
Chapter 88 |
Sulfonamides and Trimethoprim |
230 |
Chapter 89 |
Drug Therapy of Urinary Tract Infections |
232 |
Chapter 90 |
Antimycobacterial Agents: Drugs for Tuberculosis,
Leprosy, and Mycobacterium avium
Complex Infection |
235 |
Chapter 91 |
Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole, Daptomycin, Rifampin, Rifaximin,
Bacitracin, and Polymyxins |
238 |
Chapter 92 |
Antifungal Agents |
241 |
Chapter 93 |
Antiviral Agents I: Drugs for Non-HIV Viral
Infections |
245 |
Chapter 94 |
Antiviral Agents II: Drugs for HIV Infection and
Related Opportunistic Infections |
248 |
Chapter 95 |
Drug Therapy of Sexually Transmitted Diseases |
252 |
Chapter 96 |
Antiseptics and Disinfectants |
255 |
Chapter 97 |
Anthelmintics |
257 |
Chapter 98 |
Antiprotozoal Drugs I: Antimalarial Agents |
259 |
Chapter 99 |
Antiprotozoal Drugs II: Miscellaneous Agents |
262 |
Chapter 100 |
Ectoparasiticides |
264 |
Chapter 101 |
Basic Principles of Cancer Chemotherapy |
266 |
Chapter 102 |
Anticancer Drugs I:
Cytotoxic Agents |
268 |
Chapter 103 |
Anticancer Drugs II: Hormonal Agents, Targeted Drugs, and Other Noncytotoxic
Anticancer Drugs |
271 |
Chapter 104 |
Drugs for the Eye |
276 |
Chapter 105 |
Drugs for the Skin |
279 |
Chapter 106 |
Drugs for the Ear |
283 |
Chapter 107 |
Miscellaneous Noteworthy Drugs |
285 |
Chapter 108 |
Dietary Supplements |
288 |
Chapter 109 |
Management of Poisoning |
291 |
Chapter 110 |
Potential Weapons of Biologic, Radiologic, and Chemical Terrorism |
293 |
|
Answer Key |
297 |
|
|
|